Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 13, No 3 (2021) Pathogenesis, evaluation and pathogenetic therapy of diabetic polyneuropathy Abstract  similar documents
I. A. Strokov, V. V. Oganov
"... trials. The article discusses the possible disease-modifying effect of ALA. ..."
 
Vol 16, No 5 (2024) Resolution of the Expert Council on the problem of early diagnosis of Alzheimer's disease Abstract  similar documents
A. N. Bogolepova, E. E. Vasenina, N. V. Vakhnina, S. V. Vorobyеv, S. I. Gavrilova, А. Yu. Emelin, V. V. Zakharov, S. N. Illarioshkin, O. V. Kosivtsova, G. P. Kostyuk, O. S. Levin, E. A. Mkhitaryan, V. А. Parfenov, O. N. Tkacheva, Yu. A. Shpilyukova
"... (disease-modifying) AD therapies is the greatest in the early stages of the disease. An accurate diagnosis ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Alzheimer's disease Abstract  similar documents
N. N. Koberskaya
"... , the diagnosis of diseases that cause dementia makes difficulties. The review presents an update ..."
 
Vol 13, No 3 (2021) Chondroitin sulfate in osteoarthritis treatment in patients with comorbid cardiovascular diseases: hypertension, atherosclerosis, coronary heart disease Abstract  similar documents
O. A. Shavlovskaya, I. A. Bokova, I. V. Sarvilina, N. I. Shavlovskiy, Yu. D. Yukhnovskaya
"... Osteoarthritis (OA) is the most common joint disease globally, and its incidence increases ..."
 
Vol 14, No 5 (2022) Dysphagia in Alzheimer's disease Abstract  similar documents
N. N. Koberskaya
"... 's disease (AD), as a rule, at advanced stages of the disease and significantly complicates the management ..."
 
Vol 14, No 3 (2022) Combined therapy for Alzheimer's disease Abstract  similar documents
V. V. Zakharov, A. V. Lokshina, N. V. Vakhnina
"... Alzheimer's disease (AD) is the most common cause of cognitive impairment and dementia. A non ..."
 
Vol 7, No 3 (2015) Treatment for Alzheimer's diseases Abstract  similar documents
Nina Arkadyevna Tyuvina, V. V. Balabanova
"... of Alzheimer's disease (AD). It points out the role of acetylcholine and glutamatergic components ..."
 
Vol 3, No 3 (2011) Prevention of Alzheimer's disease  similar documents
V. A. Parfenov
 
Vol 14, No 2 (2022) Early-onset Alzheimer's disease Abstract  similar documents
A. B. Lokshina, D. A. Grishina, A. V. Obukhova
"... Alzheimer's disease (AD) is the most common cause of cognitive impairment in adults. There are two ..."
 
Vol 14, No 6 (2022) Alzheimer's disease and COVID-19 Abstract  similar documents
N. N. Koberskaya, F. A. Roshchin
"... -2 infection may lead to the development of Alzheimer's disease (AD) and other long-term neurological ..."
 
Vol 8, No 2 (2016) Alzheimer's disease under the mask of stroke Abstract  similar documents
A. A. Naumenko, N. V. Vakhnina
"... is frequently a neurodegenerative process and most often Alzheimer's disease (AD). Stroke may promote ..."
 
Vol 10, No 1 (2018) Sleep disorders and Alzheimer’s disease Abstract  similar documents
A. N. Bogolepova
"... Alzheimer’s disease (AD), one of the leading causes of dementia worldwide, is commonly accompanied ..."
 
Vol 8, No 4 (2016) ALZHEIMER’S DISEASE: DIAGNOSIS AND TREATMENT Abstract  similar documents
A. A. Naumenko, D. O. Gromova, N. V. Trofimova, I. S. Preobrazhenskaya
"... Early diagnosis of Alzheimer's disease (AD) is one of the most important tasks of modern medicine ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Alzheimer’s disease: diagnosis and treatment Abstract  similar documents
I. S. Preobrazhenskaya
"... ’s disease (AD), the most common cause of dementia in the elderly, are discussed. Current data ..."
 
Vol 3, No 4 (2011) New criteria for diagnosing Alzheimer's disease Abstract  similar documents
A. Yu. Emelin
"... disease (AD), which is proposed by the U.S. National Institute on Aging. It considers possibilities ..."
 
Vol 2, No 2 (2010) Symptom modifiers in therapy for ankylosing spondylitis Abstract  similar documents
V. V. Badokin
"... of ankylosing spondyloarthritis. The clinical picture and pathogenesis of this disease and the principles of its ..."
 
Vol 14, No 3 (2022) Neuropsychiatric disorders correction in Alzheimer's disease Abstract  similar documents
N. N. Koberskaya
"... Behavioral and neuropsychiatric symptoms occur in 80% of patients with Alzheimer's disease (AD ..."
 
Vol 14, No 4 (2022) The role of oxidative stress in the development of Alzheimer's disease Abstract  similar documents
V. N. Nikolenko, N. A. Rizaeva, K. V. Bulygin, V. M. Anokhina, A. A. Bolotskaya
"... Oxidative stress is one of the main mechanisms for the development of Alzheimer's disease (AD ..."
 
Vol 14, No 4 (2022) SSRI-associated apathy in Alzheimer's disease: a case series Abstract  similar documents
D. S. Petelin, A. N. Gamirova, O. N. Voskresenskaya, B. A. Volel
"... Alzheimer's disease (AD). Despite such a significant role of apathy in the course of the disease ..."
 
Vol 6, No 4 (2014) The development and treatment of Alzheimer’s disease: Some genetic aspects Abstract  similar documents
I. S. Preobrazhenskaya, N. S. Snitskaya
"... The paper gives an update on the occurrence and development of Alzheimer’s disease (AD ..."
 
Vol 15, No 6 (2023) Comorbidity of cerebral amyloid angiopathy and Alzheimer's disease. Clinical case analysis Abstract  similar documents
A. Yu. Emelin, V. Yu. Lobzin, A. Yu. Efimtsev, S. V. Vorobyov
"... combination with other nosological forms. CAA is a disease associated with both Alzheimer's type ..."
 
Vol 11, No 1 (2019) The modern concept of cognitive reserve Abstract  similar documents
N. N. Koberskaya, G. R. Tabeeva
"... reserve function in the health and disease of the brain are to activate its neuronal connections ..."
 
Vol 11, No 4 (2019) Hippocampal magnetic resonance imaging morphometry and neuropsychological parameters in patients with Alzheimer's disease Abstract  similar documents
N. N. Yakhno, N. N. Koberskaya, V. A. Perepelov, D. S. Smirnov, V. I. Solodovnikov, M. I. Trufanov, V. N. Gridin
"... Alzheimer's disease (AD) is the leading cause of dementia in the population. Difficulties ..."
 
Vol 8, No 2 (2016) Vascular and neurodegenerative cognitive impairments: a clinical case report Abstract  similar documents
V. V. Zakharov, N. V. Vakhnina
"... patient management and disease prognosis. The paper describes a patient with moderate CI, with respect ..."
 
Vol 9, No 2 (2017) Cognitive and non-cognitive neuropsychiatric disorders in dementia and methods of their correction Abstract  similar documents
E. G. Mendelevich
 
Vol 9, No 4 (2017) Current approaches to diagnosing and treating major neurocognitive disorder Abstract  similar documents
A. A. Kulesh, V. V. Shestakov
"... . It  characterizes in detail Alzheimer's disease (AD) that is a cause of  MNCD in 50–70% of cases. The current ..."
 
Vol 16, No 2 (2024) Alzheimer's disease: diagnosis and treatment, errors in patient management Abstract  similar documents
V. A. Parfenov, D. A. Grishina, A. Yu. Tyurina
"... Alzheimer's disease (AD) is the most common degenerative disease of the brain leading to dementia ..."
 
Vol 13, No 6 (2021) Treatment of noncognitive neuropsychiatric disorders in Alzheimer's disease Abstract  similar documents
A. B. Lokshina, D. A. Grishina
"... Alzheimer's disease (AD) is the most common neurodegenerative disease, which is caused by cerebral ..."
 
Vol 4, No 3 (2012) The specific features of using a rivastigmine transdermal formulation in Alzheimer’s disease Abstract  similar documents
Elena Evgenyevna Vasenina, O S Levin
"... of Meynert is one of the key factors of the development of cognitive impairments in Alzheimer’s disease (AD ..."
 
Vol 11, No 3 (2019) he amyloid hypothesis of Alzheimer's disease: past and present, hopes and disappointments Abstract  similar documents
I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova, K. M. Naumov, I. A. Lupanov, G. A. Kilivaeva, M. R. Alizade
"... , the development of the concept of the amyloid origin of Alzheimer's disease (AD) confirmed numerous relationships ..."
 
Vol 16, No 3 (2024) Biological markers of Alzheimer's disease in cerebrospinal fluid: clinical and laboratory comparisons Abstract  similar documents
K. V. Shevtsova, D. O. Rozhkov, D. A. Grishina, V. V. Grinyuk, V. V. Zakharov, N. M. Kashakanova, N. N. Koberskaya, O. V. Kosivtsova, A. B. Lokshina, Yu. A. Starchina, A. Yu. Tyurina, A. Yu. Fedorova, V. A. Parfenov
"... Diagnostic hypothesis of Alzheimer's disease (AD) is based on the typical clinical picture ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Cognitive impairments in patients with prior ischemic stroke Abstract  similar documents
V. A. Parfenov, M. A. Cherdak, N. V. Vakhnina, S. V. Verbitskaya, L. Yu. Nikitina
"... ’s disease (AD). The capacities for the diagnosis of concomitant AD in PSCI are analyzed. The treatment ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Current capacities for neuroimaging in the differential diagnosis of cognitive impairments Abstract  similar documents
A. Y. Emelin, М. М. Odinak, V. Yu. Lobzin, S. V. Vorobyev, V. N. Kiselev
"... for functional neuroimaging both in early and advanced dementias: in Alzheimer's disease, vascular dementia ..."
 
Vol 15, No 2 (2023) Rapidly progressive dementia with early onset associated with the I143T mutation in the PSEN1 gene: a clinical case in a family from Russia Abstract  similar documents
Yu. A. Shpilyukova, A. O. Protopopova, N. Yu. Abramycheva, E. Yu. Fedotova, S. N. Illarioshkin
"... the exclusion of a large number of potentially reversible causes. Prion diseases are frequent in this group ..."
 
Vol 14, No 2 (2022) New potential biomarkers of Alzheimer's disease: markers of endothelial dysfunction and neuroinflammation. Abstract  similar documents
A. K. Minochkin, V. Yu. Lobzin, N. N. Suchentseva, O. S. Popov, S. V. Apalko, S. G. Sherbak
"... Alzheimer's disease (AD) is the most common cause of dementia in the elderly. The aim of the work ..."
 
Vol 10, No 3 (2018) Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders Abstract  similar documents
E. G. Mendelevich
"... worldwide. The clinical presentation of Alzheimer's disease at one or another stage is accompanied ..."
 
Vol 9, No 3 (2017) Current views of the risk factors, diagnosis, and therapy of Alzheimer's disease (according to the proceedings of the Alzheimer's Association International Conference, London, 2017) Abstract  similar documents
N. N. Koberskaya
"... of Alzheimer's disease (AD) according to the proceeding of the Alzheimer's Association International Conference ..."
 
Vol 17, No 1 (2025) Subjective and functional cognitive impairment: diagnostics using biological markers of Alzheimer's disease Abstract  PDF (Eng)  similar documents
V. A. Parfenov, D. A. Grishina, A. B. Lokshina, V. V. Zakharov, K. V. Shevtsova, Ya. I. Chervyakova
"... the manifestations and diagnostic issues of SCI and FCI and the possibilities of diagnosing Alzheimer's disease (AD ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Neuroimaging techniques for diagnosing Alzheimer’s disease and cerebrovascular diseases with cognitive impairment Abstract  similar documents
I. V. Litvinenko, A. Yu. Emelin, V. Yu. Lobzin, K. A. Kolmakova
"... The paper provides data on current neuroimaging techniques for diagnosing Alzheimer’s disease ..."
 
Vol 11, No 3 (2019) Vascular cognitive impairment and Alzheimer's disease: Is there a relationship between them? Abstract  similar documents
G. R. Tabeeva, E. A. Kirjanova
"... on the clinical manifestation, severity, and rate of progression of CI. Alzheimer's disease (AD) and vascular CI ..."
 
Vol 4, No 2S (2012): Сognitive and other neuropsychiatric disorders Akatinol in the treatment of noncognitive neuropsychological disorders in neurogeriatric diseases Abstract  similar documents
T. G. Voznesenskaya
"... ) with non-dementia cognitive impairments (CI) and in Alzheimer’s disease (AD) with mild to moderate stage ..."
 
Vol 16, No 2 (2024) Diagnosis of Alzheimer's disease by using biological markers in posterior cortical atrophy Abstract  similar documents
D. A. Grishina, N. A. Khayalieva, V. V. Grinyuk, A. Yu. Tyurina
"... The use of biological markers for Alzheimer's disease (AD) allows diagnosis at the stage ..."
 
Vol 12, No 6 (2020) Normal pressure hydrocephalus and cerebral amyloid angiopathy: a set of diseases or the unity of pathogenesis? Abstract  similar documents
E. G. Mendelevich
"... by a wide range of controversial issues related to the prevalence of the disease, the mechanisms of its ..."
 
Vol 14, No 4 (2022) Cognitive impairment in patients with coronavirus infection Abstract  similar documents
Y. A. Starchina, O. V. Kosivtsova
"... the clinical onset and progression of CI, including Alzheimer's disease. For the treatment of severe CI after ..."
 
Vol 12, No 4 (2020) Depression and dementia: differentiation and comorbidity Abstract  similar documents
V. Yu. Lobzin, A. Yu. Emelin
"... be one of the symptoms of Alzheimer’s disease or may precede the onset of CI. Depression also has ..."
 
Vol 10, No 2 (2018) Current management tactics for patients with dementia Abstract  similar documents
A. V. Medvedeva, O. V. Kosivtsova, K. A. Makhinov
 
Vol 11, No 3 (2019) Cognitive impairment in depression and Alzheimer's disease: differential diagnosis and approaches to therapy Abstract  similar documents
N. A. Tyuvina, S. V. Prokhorova, T. N. Maksimova, M. S. Verbitskaya
"... neuropsychiatric diseases, including Alzheimer's disease (AD) and depression. The literature review presents ..."
 
Vol 4, No 2 (2012) Artra is a model of combination symptom-modifying therapy for osteoarthrosis and intervertebral osteochondrosis Abstract  similar documents
V V Badokin
"... Препарат артра — модель комбинированной симптом-модифицирующей терапии остеоартроза и ..."
 
Vol 7, No 4 (2015) Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use Abstract  similar documents
N. V. Trofimova, I. S. Preobrazhenskaya
"... a positive effect on cognitive functions in patients with Alzheimer’s disease if it is used as an additional ..."
 
Vol 11, No 4 (2019) Errors in the management of patients with Alzheimer's disease: analysis of problems and ways of their solution Abstract  similar documents
A. Yu. Emelin, I. V. Litvinenko, V. Yu. Lobzin
"... Epidemiological data show that Alzheimer's disease (AD) is the most common cause of acquired ..."
 
Vol 8, No 3 (2016) Prevention of cerebrovascular diseases and cognitive impairment in psychiatric and neurological practice: A literature review Abstract  similar documents
A. G. Merkin, V. A. Kazhin, A. N. Komarov, A. V. Fonarev, V. A. Priyatel, I. A. Nikiforov
"... the burden of diseases and overloads healthcare systems. Therefore prevention strategies are currently ..."
 
Vol 15, No 6 (2023) Choline alfoscerate in the correction of cognitive impairment Abstract  similar documents
O. A. Shavlovskaya, I. D. Romanov, I. A. Bokova
"... be recommended both as monotherapy and as part of complex therapy in patients with cerebrovascular diseases ..."
 
Vol 13, No 1 (2021) Clinical manifestations and issues of diagnosis of chronic cerebrovascular disease (chronic cerebral ischemia) at an early (pre-dementia) stage Abstract  PDF (Eng)  similar documents
A. A. Kulesh, A. Yu. Emelin, A. N. Bogolepova, O. B. Doronina, V. V. Zakharov, O. V. Kolokolov, S. V. Kotov, L. L. Korsunskaya, M. A. Kutlubaev, V. B. Laskov, O. S. Levin, V. A. Parfenov
"... cerebrovascular disease (CVD) (chronic cerebral ischemia (CCI) and dyscirculatory encephalopathy (DEP)) at the pre ..."
 
Vol 15, No 1 (2023) Management of patients with cognitive impairment Abstract  similar documents
V. A. Parfenov
"... . In our country, CI is poorly diagnosed, the most common cause of CI in the elderly – Alzheimer's disease ..."
 
Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) Abstract  similar documents
V. A. Parfenov
"... up with a diagnosis of CCI, DEP, have no signs of chronic cerebrovascular disease (CVD), but suffer ..."
 
Vol 11, No 1 (2019) Cerebrospinal fluid biomarkers in idiopathic normal pressure hydrocephalus Abstract  similar documents
B. G. Adleyba, G. V. Gavrilov, A. V. Stanishevsky, B. V. Gaydar, D. V. Svistov, V. Yu. Lobzin, K. A. Kolmakova
"... of the same symptomatology in neurodegenerative diseases. The data of brain magnetic resonance imaging (MRI ..."
 
Vol 1, No 3-4 (2009) NEUROPSYCHOLOGICAL APPROACH TO STUDYING NORMAL AND ABNORMAL AGING Abstract  similar documents
N. K. Korsakova, I. F. Roshchina
"... in presenile (early) and senile (late) types of Alzheimer's disease ..."
 
Vol 5, No 4 (2013) Dementia: epidemiology, clinical picture, diagnosis, approaches to therapy Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
"... ’s disease, Lewy body dementia, and vascular dementia. The paper outlines basic approaches ..."
 
Vol 11, No 4 (2019) Digital technologies in the diagnosis and treatment of neurological diseases Abstract  similar documents
N. V. Petukhova, M. P. Farkhadov, M. V. Zamegrad, S. P. Grachev
"... image processing, as well as to the diagnosis of neurological diseases based on computer-aided analysis ..."
 
Vol 5, No 4 (2013) Sleep disorders and their significance in the development of cognitive impairments Abstract  similar documents
Irina Sergeyevna Preobrazhenskaya
 
Vol 6, No 2 (2014) Voxel-based moprhometry in the differential diagnosis of posttraumatic cognitive impairments Abstract  similar documents
M.M. Odinak, S.V. Vorobyev, V.А. Fokin, A.Yu. Emelin, V.Yu. Lobzin, A.V. Sokolov
 
Vol 5, No 4 (2013) Value of determining the cerebrospinal fluid protein markers of amyloidosis and neurodegeneration in the diagnosis of vascular and neurodegenerative cognitive impairments Abstract  similar documents
Vladimir Yuryevich Lobzin, A Yu Emelin, M M Odinak, L A Alekseeva, N E Monakhova
"... patients with Alzheimer’s disease (AD), and 23 patients with mixed vascular and neurodegenerative dementia ..."
 
Vol 12, No 5 (2020) NMDA receptor antagonists in the treatment of neurological diseases Abstract  similar documents
I. S. Preobrazhenskaya
"... antagonists used to treat various neurological diseases: neurodegenerative dementias, vascular cognitive ..."
 
Online-first Магнитно-резонансная морфометрия гиппокампов и нейропсихологические показатели у пациентов с болезнью Альцгеймера Abstract  similar documents
Н. Н. Яхно, Н. Н. Коберская, В. А. Перепелов, Д. С. Смирнов, В. И. Солодовников, М. И. Труфанов, В. Н. Гридин
"...   Болезнь Альцгеймера (БА) является ведущей причиной развития деменции в популяции. Сложности ..."
 
Vol 15, No 2 (2023) The use of antidepressants in neurological practice Abstract  similar documents
V. A. Parfenov
"... 's disease, depression with cognitive impairment, Parkinson's disease, multiple sclerosis, chronic back pain ..."
 
Vol 10, No 4 (2018) Cognitive and motor training for patients with moderate cognitive impairment and mild dementia Abstract  similar documents
A. A. Naumenko, I. S. Preobrazhenskaya
"... method to basic therapy in patients with Alzheimer's disease (AD) and vascular cognitive impairment (VCI ..."
 
Vol 15, No 2 (2023) New pharmaconutraceutical Chondroguard®TRIO for the prevention of musculoskeletal diseases and nutritional support for patients with osteoarthritis and nonspecific back pain: an assessment of clinical options. Resolution of the Multidisciplinary Expert Council Abstract  similar documents
Al. B. Danilov, A. M. Lila, Yo. N. Majidova, O. A. Gromova, O. N. Tkacheva, I. V. Sarvilina, A. Yu. Kochish, A. G. Nazarenko, N. V. Zagorodniy, T. B. Minasov, L. I. Alekseeva, E. A. Taskina, Yu. V. Kotovskaya, E. N. Dudinskaya, A. V. Rozanov, E. Yu. Solovieva, O. A. Shavlovskaya, M. N. Sharov, P. R. Kamchatnov, A. P. Rachin, E. R. Barantsevich, D. A. Iskra, E. Z. Yakupov, F. I. Devlikamova, A. E. Barulin, M. V. Nesterova, T. G. Sakovets, A. N. Barinov, I. N. Dolgova, N. V. Zabolotskikh, E. V. Zonova, L. A. Shchepankevich, V. A. Parfenov, A. T. Dzhurabekova, S. Z. Khakimova
"... for the effectiveness and safety of the use of drugs that modify the course of OA (Disease-modifying osteoarthritis ..."
 
Vol 3, No 1 (2011) Meniere's disease Abstract  similar documents
M. V. Zamergrad, O. A. Mel'nikov
"... Meniere's disease is one of the most common causes of recurrent vestibular vertigo. Despite its ..."
 
Vol 10, No 1 (2018) Headache in elderly patients with chronic cerebral ischemia: outpatient diagnosis and treatment Abstract  similar documents
M. P. Platov, O. V. Kosivtsova
"... walking, and lower mood. At the same time, other diseases that cause these symptoms are not diagnosed ..."
 
Vol 13, No 2 (2021) COVID-19 vaccination guidelines for patients with multiple sclerosis Abstract  similar documents
N. V. Khachanova, N. A. Totolyan, Ya. V. Vlasov, S. A. Sivertseva, M. V. Davydovskaya, E. P. Evdoshenko, A. P. Prodeus, M. N. Zakharova, N. N. Spirin, A. N. Boyko
"... . Preliminary recommendations are given for COVID-19 vaccination, taking into account the MS disease modifying ..."
 
1 - 70 of 806 Items 1 2 3 4 5 6 7 8 9 10 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)